Benjamin D. Hedley

1.7k total citations
40 papers, 1.1k citations indexed

About

Benjamin D. Hedley is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Benjamin D. Hedley has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 11 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Benjamin D. Hedley's work include Acute Myeloid Leukemia Research (9 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer Cells and Metastasis (6 papers). Benjamin D. Hedley is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer Cells and Metastasis (6 papers). Benjamin D. Hedley collaborates with scholars based in Canada, United States and United Kingdom. Benjamin D. Hedley's co-authors include Alison L. Allan, Carl O. Postenka, Ann F. Chambers, David Goodale, Jenny E. Chu, David A. Hess, Alysha K. Croker, Michael Keeney, Anargyros Xenocostas and Ian Chin‐Yee and has published in prestigious journals such as Blood, Clinical Cancer Research and International Journal of Cancer.

In The Last Decade

Benjamin D. Hedley

34 papers receiving 1.0k citations

Peers

Countries citing papers authored by Benjamin D. Hedley

Since Specialization

Citations

This map shows the geographic impact of Benjamin D. Hedley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin D. Hedley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin D. Hedley more than expected).

Fields of papers citing papers by Benjamin D. Hedley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin D. Hedley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin D. Hedley. The network helps show where Benjamin D. Hedley may publish in the future.

Co-authorship network of co-authors of Benjamin D. Hedley

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin D. Hedley. A scholar is included among the top collaborators of Benjamin D. Hedley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin D. Hedley. Benjamin D. Hedley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Maternal and fetal pharmacokinetics (PK) of pegcetacoplan in paroxysmal nocturnal hemoglobinuria (PNH): A case report of use in pregnancy 2025 ·Blood ·Benjamin Chin‐Yee, Benjamin D. Hedley, Rui Su, Barbra de Vrijer, Facundo García‐Bournissen, Sarah Parkinson, Cyrus C. Hsia, Matthew Nichols, Ian Chin‐Yee, Christopher J. Patriquin	0
2	Paroxysmal Nocturnal Hemoglobinuria in Pregnancy Treated With Pegcetacoplan: Case Report and Pharmacokinetic Analysis 2025 ·eJHaem ·Benjamin Chin‐Yee, Benjamin D. Hedley, Rui Su, Barbra de Vrijer, Facundo García‐Bournissen, Sarah Parkinson, Cyrus C. Hsia, Matthew Nichols, Ian Chin‐Yee, (unknown)	0
3	Ad hoc antibody modification of a validated flow cytometric immunophenotyping panel—recommendations and safeguards for clinical laboratories 2025 ·Cytometry Part B Clinical Cytometry ·Christopher J. Groves, Michael A. Linden, Ahmad Al‐Attar, Michael J. Borowitz, (unknown), Marci O’Driscoll, (unknown), (unknown), Thomas C. Beadnell, (unknown), (unknown), Robert J. Durso, Sara A. Monaghan, Benjamin D. Hedley	0
4	TAF15::ZNF384 Mixed Phenotype Acute Leukemia With Complex Karyotype: Case Report With B‐ ALL Induction, Blinatumomab Bridging to Allogeneic Transplant and Literature Review 2025 ·Clinical Case Reports ·(unknown), (unknown), (unknown), Benjamin D. Hedley, Jean McGowan‐Jordan, Ruth Padmore	0
5	Implementation of flow cytometry testing on rare matrix samples: Special considerations and best practices when the sample is unique or difficult to obtain 2024 ·Cytometry Part B Clinical Cytometry ·(unknown), Wolfgang Kern, Małgorzata Kajstura, Eda K. Holl, Amanda Hays, Benjamin D. Hedley, (unknown), Evan R. Jellison, Thomas W. McCloskey, (unknown), Jennifer Rebeles, Madhu M. Ouseph	1
6	Myelodysplastic Neoplasms (MDS) with Ring Sideroblasts or SF3B1 Mutations: The Improved Clinical Utility of World Health Organization and International Consensus Classification 2022 Definitions, a Single-Centre Retrospective Chart Review 2024 ·Current Oncology ·(unknown), Benjamin Chin‐Yee, (unknown), Ian Chin‐Yee, Benjamin D. Hedley, Jenny Ho, (unknown), Alejandro Lazo‐Langner, Laila C. Schenkel, (unknown), Bekim Sadiković, (unknown), Nikhil Sangle, Cyrus C. Hsia	3
7	Enhanced detection and Characterization of M-proteins in multiple myeloma patients using An Agilent AssayMAP Bravo liquid handling system coupled to an LC-QTOF 2024 ·Clinical Biochemistry ·Matthew Nichols, (unknown), Martha Louzada, Benjamin D. Hedley, Vipin Bhayana, (unknown), Angela C. Rutledge	0
8	Clinical Utility of Implementing a Frontline NGS-Based DNA and RNA Fusion Panel Test for Patients with Suspected Myeloid Malignancies 2022 ·Molecular Diagnosis & Therapy ·(unknown), Cyrus C. Hsia, Laila C. Schenkel, Benjamin D. Hedley, Michael A. Levy, Jennifer Kerkhof, (unknown), Alan Stuart, Hanxin Lin, (unknown), (unknown), Ping Yang, Anargyros Xenocostas, Ian Chin‐Yee, Bekim Sadiković	8
9	Reducing cytogenetic testing in the era of next generation sequencing: Are we choosing wisely? 2021 ·International Journal of Laboratory Hematology ·Eri Kawata, Benjamin D. Hedley, Benjamin Chin‐Yee, Anargyros Xenocostas, Alejandro Lazo‐Langner, Cyrus C. Hsia, Kang Howson‐Jan, Ping Yang, Michael A. Levy, (unknown), (unknown), Christopher J. Howlett, Hanxin Lin, Mike Kadour, Bekim Sadiković, Ian Chin‐Yee	2
10	Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies 2021 ·Cell Reports Methods ·Sally Esmail, Michael J. Knauer, (unknown), Courtney Voss, Benjamin Chin‐Yee, P.J. Stogios, Almagul Seitova, Ashley Hutchinson, (unknown), T. Skarina, E. Evdokimova, Suzanne Ackloo, Lori E. Lowes, Benjamin D. Hedley, Vipin Bhayana, Ian Chin‐Yee, Shawn S.‐C. Li	11
11	Experience with MRD Testing in B- ALL By Flow Cytometry Does Not Prevent Interpretative Discordance 2016 ·Blood ·Michael Keeney, Brent L. Wood, Benjamin D. Hedley, Joseph A. DiGiuseppe, Maryalice Stetler‐Stevenson, Elisabeth Paietta, Gerard Lozanski, Adam C. Seegmiller, Bruce Greig, Aaron C. Shaver, Lata Mukundan, Howard R. Higley, Caroline C. Sigman, Gary Kelloff, J. Milburn Jessup, Michael J. Borowitz	1
12	Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications 2014 ·Journal of Visualized Experiments ·Lori E. Lowes, Benjamin D. Hedley, Michael Keeney, Alison L. Allan	9
13	User‐defined protein marker assay development for characterization of circulating tumor cells using the CellSearch® system 2012 ·Cytometry Part A ·Lori E. Lowes, Benjamin D. Hedley, Mike Keeney, Alison L. Allan	18
14	Recombinant Human Erythropoietin in Combination with Chemotherapy Increases Breast Cancer Metastasis in Preclinical Mouse Models 2011 ·Clinical Cancer Research ·Benjamin D. Hedley, Jenny E. Chu, (unknown), (unknown), (unknown), Alison L. Allan, Anargyros Xenocostas	25
15	Initial performance evaluation of the UniCel^® DxH 800 Coulter^® cellular analysis system 2010 ·International Journal of Laboratory Hematology ·Benjamin D. Hedley, Michael Keeney, Ian Chin‐Yee, William D. Brown	19
16	High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability 2008 ·Journal of Cellular and Molecular Medicine ·Alysha K. Croker, David Goodale, Jenny E. Chu, Carl O. Postenka, Benjamin D. Hedley, David A. Hess, Alison L. Allan	416
17	BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiation 2008 ·Clinical & Experimental Metastasis ·Benjamin D. Hedley, Kedar S. Vaidya, (unknown), Lisa T. MacKenzie, David W. Dales, Carl O. Postenka, Ian C. MacDonald, Ann F. Chambers	36
18	Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1 2008 ·International Journal of Cancer ·Benjamin D. Hedley, Danny R. Welch, Alison L. Allan, Waleed Al‐Katib, David W. Dales, Carl O. Postenka, Graham Casey, Ian C. MacDonald, Ann F. Chambers	39
19	The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms 2007 ·Breast Cancer Research and Treatment ·(unknown), Benjamin D. Hedley, David Goodale, Carl O. Postenka, Waleed Al‐Katib, Alan B. Tuck, Ann F. Chambers, Alison L. Allan	45
20	Therapeutic targets for antimetastatic therapy 2004 ·Expert Opinion on Therapeutic Targets ·Benjamin D. Hedley, Eric Winquist, Ann F. Chambers	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact